Clinical Trials List
Protocol NumberL00070 IN 213 P1
2011-03-01 - 2013-12-31
Phase II
Terminated2
ICD-10C68.9
Malignant neoplasm of urinary organ, unspecified
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9189.9
Malignant neoplasm of urinary organ, site unspecified
-
Trial Applicant
Orient EuroPharma Co., Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/19
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Peng-Chan Lin Division of Hematology & Oncology
- Chia-Jui Yen Division of Hematology & Oncology
- Wen-Pin Su Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
68 participants
